Summary: Researchers have uncovered a neural mechanism in female mice that shifts estrogen from playing a protective role in glucose metabolism to a disruptive one.
Source: Tufts University
Researchers at Tufts University School of Medicine and Tufts Graduate School of Biomedical Sciences have discovered neural mechanisms in mice specific to females that can shift estrogen from playing a protective role in glucose metabolism to one that is disruptive. The authors of the study, published online in the Proceedings of the National Academies of Sciences (PNAS), hypothesize that the metabolic “switch” mediated by estrogen may provide clues to the increased risk of insulin resistance and diabetes among post-menopausal women.
The study focused on a region of the brain called the ventromedial hypothalamus (VMH) and found that the removal of the metabotropic glutamate receptor 5 (mGluR5) in that area caused estrogen to reduce the activity of neurons important for glycemic control, leading to insulin resistance and glucose intolerance. These effects were opposite to the increased neuronal activity and enhanced glucose metabolism observed in mice with the receptor following estrogen delivery. The paradoxical outcome on glucose metabolism was seen in female, but not male, mice.
Prior research by others had indicated that the VMH region of the brain plays a role in managing appropriate levels of glucose production in the liver and utilization of circulating glucose by cells and tissues. Within the VMH, steroidogenic factor 1 (SF1) neurons are responsible for helping to regulate glucose as well as lipid levels, e.g. cholesterol and triglycerides. However, less was known about exactly how the VMH regulates glucose metabolism. Similarly, while the beneficial effects of estrogen have long been recognized, the mechanisms driving these effects remain poorly understood.
mGluR5 is highly expressed in the VMH and is known to regulate neuron activity in other parts of the brain. When the researchers knocked out the expression of mGluR5 specifically in the VMH using gene editing methods, they observed a reduction of SF1 neuron activity and a disruption of normal glucose regulation, but only in the female mice.
Knocking out mGluR5 in male mice did not have these effects and their glucose metabolism remained normal.
Noting different effects on glucose metabolism between male and female mice, the researchers examined the potential involvement of sex hormones. They discovered that estrogen, which normally promotes metabolic health in females, supports glycemic control only when mGluR5 is present in the VMH. Without mGluR5, estrogen actually suppresses the neurons responsible for regulating glucose – it becomes a metabolic liability.
“Our findings show that the glutamate receptor is essential for the effects of estrogen regulating proper glucose levels and utilization in females, whereas it does not appear to play that regulatory role in males. This could give us insight into many of the differences between men and women in their risk of diabetes and disease progression throughout life,” said senior author Maribel Rios, researcher in neuroscience at Tufts School of Medicine and a member of the neuroscience and cell, molecular and developmental biology program faculties at Tufts Graduate School of Biomedical Sciences.
Co-first authors are Micaella P. Fagan and Dominique Ameroso, both of the neuroscience program at Tufts Graduate School of Biomedical Sciences.
About this neuroscience research article
Source: Tufts University Contacts: Angelina Sutin – Tufts University Image Source: The image is in the public domain.
Essential and sex-specific effects of mGluR5 in ventromedial hypothalamus regulating estrogen signaling and glucose balance
The ventromedial hypothalamus (VMH) plays chief roles regulating energy and glucose homeostasis and is sexually dimorphic. We discovered that expression of metabotropic glutamate receptor subtype 5 (mGluR5) in the VMH is regulated by caloric status in normal mice and reduced in brain-derived neurotrophic factor (BDNF) mutants, which are severely obese and have diminished glucose balance control. These findings led us to investigate whether mGluR5 might act downstream of BDNF to critically regulate VMH neuronal activity and metabolic function. We found that mGluR5 depletion in VMH SF1 neurons did not affect energy balance regulation. However, it significantly impaired insulin sensitivity, glycemic control, lipid metabolism, and sympathetic output in females but not in males. These sex-specific deficits are linked to reductions in intrinsic excitability and firing rate of SF1 neurons. Abnormal excitatory and inhibitory synapse assembly and elevated expression of the GABAergic synthetic enzyme GAD67 also cooperate to decrease and potentiate the synaptic excitatory and inhibitory tone onto mutant SF1 neurons, respectively. Notably, these alterations arise from disrupted functional interactions of mGluR5 with estrogen receptors that switch the normally positive effects of estrogen on SF1 neuronal activity and glucose balance control to paradoxical and detrimental. The collective data inform an essential central mechanism regulating metabolic function in females and underlying the protective effects of estrogen against metabolic disease.